Percutaneous transhepatic extraction and balloon dilation for simultaneous gallbladder stones and common bile duct stones: A novel technique

作者
Bin Liu,De-Shun Wu,Pikun Cao,Yongzheng Wang,Wujie Wang,Wei Wang,Haiyang Chang,Dong Li,Xiao Li,Yancu Hertzanu,Yuliang Li
出处
期刊:World Journal of Gastroenterology [Baishideng Publishing Group]
卷期号:24 (33): 3799-3805 被引量:17
标识
DOI:10.3748/wjg.v24.i33.3799
摘要

AIM: To evaluate the clinical efficacy and safety of an innovative percutaneous transhepatic extraction and balloon dilation (PTEBD) technique for clearance of gallbladder stones in patients with concomitant stones in the common bile duct (CBD). METHODS: The data from 17 consecutive patients who underwent PTEBD for clearance of gallbladder stones were retrospectively analyzed. After removal of the CBD stones by percutaneous transhepatic balloon dilation (PTBD), the gallbladder stones were extracted to the CBD and pushed into the duodenum with a balloon after dilation of the sphincter of Oddi. Large stones were fragmented using a metallic basket. The patients were monitored for immediate adverse events including hemorrhage, perforation, pancreatitis, and cholangitis. During the two-year follow-up, they were monitored for stone recurrence, reflux cholangitis, and other long-term adverse events. RESULTS: Gallbladder stones were successfully removed in 16 (94.1%) patients. PTEBD was repeated in one patient. The mean hospitalization duration was 15.9 ± 2.2 d. Biliary duct infection and hemorrhage occurred in one (5.9%) patient. No severe adverse events, including pancreatitis or perforation of the gastrointestinal or biliary tract occurred. Neither gallbladder stone recurrence nor refluxing cholangitis had occurred two years after the procedure. CONCLUSION: Sequential PTBD and PTEBD are safe and effective for patients with simultaneous gallbladder and CBD stones. These techniques provide a new therapeutic approach for certain subgroups of patients in whom endoscopic retrograde cholangiopancreatography/endoscopic sphincterotomy or surgery is not appropriate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无敌小车发布了新的文献求助10
刚刚
hh完成签到,获得积分10
刚刚
开开开完成签到,获得积分10
1秒前
zb2009gy发布了新的文献求助10
1秒前
南风向北完成签到,获得积分10
1秒前
李爱国的应助被潘多拉采纳,获得10
1秒前
1秒前
段培炎发布了新的文献求助10
1秒前
无昵称完成签到,获得积分10
1秒前
2秒前
2秒前
kdfdds完成签到,获得积分10
2秒前
清i晨完成签到,获得积分10
2秒前
2秒前
2秒前
清秋1001完成签到,获得积分10
3秒前
Sunflower发布了新的文献求助10
3秒前
深情安青的应助被魔音甜菜采纳,获得10
3秒前
ral完成签到,获得积分10
3秒前
手机打卡开不开完成签到,获得积分10
4秒前
4秒前
Allen完成签到,获得积分10
4秒前
江心秋月发布了新的文献求助10
4秒前
孙朱珠完成签到,获得积分10
5秒前
5秒前
hh发布了新的文献求助10
5秒前
大意的忆安完成签到,获得积分10
5秒前
田様的应助被泥盆纪的鱼采纳,获得10
5秒前
美年达发布了新的文献求助10
6秒前
无奈完成签到,获得积分10
6秒前
小茉莉发布了新的文献求助30
7秒前
洋芋二号发布了新的文献求助10
7秒前
小巧天亦完成签到,获得积分10
7秒前
诸葛语蝶完成签到,获得积分10
7秒前
bingbing发布了新的文献求助10
8秒前
8秒前
晓君完成签到,获得积分10
8秒前
Hzml完成签到 ,获得积分10
8秒前
世界首富一姐完成签到,获得积分10
8秒前
Hellowa完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Sustainable Engineered Micro/Nanofibers and Hybrid Nanocomposites for Environmental Remediation 400
Ecotourism 400
Liquidus diagram and viscosity estimation in pseudo-binary system Li2B6O10–LiF 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8076652
求助须知:如何正确求助?哪些是违规求助? 9494616
关于积分的说明 21382290
捐赠科研通 7644690
什么是DOI,文献DOI怎么找? 3400174
关于科研通互助平台的介绍 2529895
邀请新用户注册赠送积分活动 2438810